IMPACT 2017 | Parker Institute for Cancer Immunotherapy -Tumor Epitope Selection Alliance (TESLA) - a podcast by Cambridge Healthtech Podcasts
from 2017-07-28T19:46:06
::
::
Danny Wells speaks to CHI on July 6th, 2017. Dr. Wells will be speaking during Neoantigen-Based Personalized Immunotherapies meeting at ImPACT: Immunotherapy Progress and Clinical Treatments, December 5-7th, 2018 in San Diego, California.
Topics include scaling up personalized therapies, future clinical applications of neoantigens, and new frontiers in cancer immunotherapy.
For more information, please visit http://www.ImpactImmunotherapy.com/Neoantigen-Immunotherapy/
Further episodes of CHI Podcasts
Further podcasts by Cambridge Healthtech Podcasts
Website of Cambridge Healthtech Podcasts